Work

Phase II study of Hyper-CVAD with pegylated liposomal doxorubicin alternating with methotrexate and cytarabine (HCVIDD/MA) in patients with newly diagnosed T- and NK-cell lymphoma (T/NKCL).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8538

Authors: Dai Chihara, Barbara Pro, Sanam Loghavi, Roberto N. Miranda, L Jeffrey Medeiros, Michelle A. Fanale, Frederick B. Hagemeister, Luis Fayad, Jorge Enrique Romaguera, Felipe Samaniego, Sattva Swarup Neelapu, Anas Younes, Nathan Hale Fowler, Maria Alma Rodriguez, Michael Wang, Larry W. Kwak, Peter McLaughlin, Nam H. Dang, Yasuhiro Oki

Institutions: The University of Texas MD Anderson Cancer Center, Thomas Jefferson University Hospital, Memorial Sloan Kettering Cancer Center, University of Florida

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600236853

Cites:

Cited by:

Related to: 10